Cellebrite DI (CLBT) Receivables - Other (2020 - 2025)

Cellebrite DI has reported Receivables - Other over the past 6 years, most recently at $78.6 million for Q4 2025.

  • Quarterly results put Receivables - Other at $78.6 million for Q4 2025, down 3.41% from a year ago — trailing twelve months through Dec 2025 was $78.6 million (down 3.41% YoY), and the annual figure for FY2025 was $78.6 million, down 3.41%.
  • Receivables - Other for Q4 2025 was $78.6 million at Cellebrite DI, down from $81.3 million in the prior quarter.
  • Over the last five years, Receivables - Other for CLBT hit a ceiling of $89.2 million in Q4 2023 and a floor of $72.3 million in Q4 2021.
  • Median Receivables - Other over the past 5 years was $81.3 million (2024), compared with a mean of $80.6 million.
  • Biggest five-year swings in Receivables - Other: surged 113.13% in 2021 and later dropped 8.78% in 2024.
  • Cellebrite DI's Receivables - Other stood at $72.3 million in 2021, then increased by 12.83% to $81.5 million in 2022, then rose by 9.38% to $89.2 million in 2023, then decreased by 8.78% to $81.3 million in 2024, then decreased by 3.41% to $78.6 million in 2025.
  • The last three reported values for Receivables - Other were $78.6 million (Q4 2025), $81.3 million (Q4 2024), and $89.2 million (Q4 2023) per Business Quant data.